表紙
市場調查報告書
商品編碼
1020027

營養基因學的全球市場 (2021-2031年):市場預測 (各用途、類型)、各國資料 (15個國家)、產業分析、競爭環境

Global Nutrigenomics Market: Focus on Application, Type, 15 Countries Data, Industry Insights, and Competitive Landscape - Analysis and Forecast, 2021-2031

出版日期: | 出版商: BIS Research Inc. | 英文 166 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球營養基因學的市場規模預計2031年成長到51億7060萬美元的規模。

本報告提供全球營養基因學的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律制度,專利趨勢,市場規模的變化、預測,用途、類型、地區等各種區分的明細,競爭環境,市場佔有率,主要企業簡介等彙整資訊。

第1章 營養基因學:產品定義

第2章 調查手法

第3章 市場概要

  • 個體化食品的營養基因學的演進
  • 營養遺傳學和營養基因學
  • 營養基因學的遺傳基因檢驗方案
  • COVID-19的影響
  • COVID-19供應鏈的影響
  • 研究、臨床開發及商業運用的中斷
  • 自危機復甦

第4章 產業分析

  • 相關法規:各地區
  • 專利情勢

第5章 市場動態

  • 市場推進因素
  • 市場抑制因素
  • 市場機會
  • 償付方針的轉移

第6章 競爭情形

  • 主要的展開、策略
  • 新產品
  • 聯盟、聯盟
  • 資金籌措、投資、事業擴大
  • M&A
  • 其他策略
  • 市場佔有率分析
  • 成長佔有率分析

第7章 市場分析、預測:各用途

  • 女性的健康
  • 消化器官的健康
  • 免疫的健康
  • 其他

第8章 市場分析、預測:各類型

  • 各產品
    • 益生菌
    • 益生元、營養補充品
  • 各類服務
    • 營養基因學遺傳基因檢驗(臨床)
    • 營養基因學遺傳基因檢驗(研究)

第9章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他地區

第10章 企業簡介

  • BioGaia
  • DuPont de Nemours, Inc.
  • Nutrigenomix Inc.
  • MedGenome
  • Garden of Life, LLC
  • Ingredion Incorporated
  • Jarrow Formulas Inc.
  • geneOmbio
  • GX Sciences, Inc.
  • DNAfit
  • Yakult Honsha Co., Ltd.
  • Koninklijke DSM N.V.
  • XCODE Life
目錄
Product Code: BHP1100SA

“Global Nutrigenomics Market to Reach $5,170.6 Million by 2031.”

Market Report Coverage - Nutrigenomics

Market Segmentation

  • Application - Women's Health, Digestive Health, Immune Health, and Others
  • Type - by Product (Probiotics and Prebiotics and Dietary Supplements) and by Service (Nutrigenomics Genetic Testing For Clinical Purpose and Nutrigenomics Genetic Testing For Research)

Regional Segmentation

  • North America - U.S. and Canada
  • Europe - U.K., Germany, France, Italy, Spain
  • Asia-Pacific - Japan, China, India, Australia, and Rest-of-Asia-Pacific
  • Latin America - Brazil, Mexico, and Rest-of-Latin America
  • Rest-of-the-World

Market Growth Drivers

  • Rising Advancement in Genomics Technology
  • Increasing Incidence of Lifestyle-Related Diseases
  • Increasing Demand for Preventive Medication Through Personalized Nutrition
  • Limited Efficacy Rate of Drugs

Market Challenges

  • Insufficient Application-Based Research Hindering Market Pull
  • Lack of Awareness Regarding the Usage of Probiotics and Prebiotics
  • Non-Harmonized Government Regulations on Probiotics and Prebiotics Focusing on Nutrigenomics

Market Opportunities

  • Massive Scope for Phenomenal Profits Through Venturous Investments
  • Integrative Industry-Academia Collaboration
  • Rise of Next-Generation Probiotics
  • Shifting of Reimbursement Policies Toward Enhanced Genetics Coverage

Key Companies Profiled

BioGaia, DuPont de Nemours, Inc., Nutrigenomix Inc., MedGenome, Garden of Life, LLC, Ingredion Incorporated, Jarrow Formulas Inc., geneOmbio, GX Sciences, Inc., DNAfit, Yakult Honsha Co., Ltd., Koninklijke DSM N.V., XCODE Life.

Key Questions Answered in this Report:

  • What are the most common genetic conditions that have a significant role of nutrition metabolism?
  • What emerging trends are being followed by the companies in the global nutrigenomics market?
  • How are the key market players performing research investments in the respective market?
  • What are the major strategies opted by the key players for advancing in the global nutrigenomics market?
  • What are the regulations pertaining to the global nutrigenomics market among different regions and their impact on respective markets?
  • What are the initiatives implemented by different government bodies regulating the development and commercialization of nutrigenomic tests and associated platforms?
  • How has COVID-19 impacted the global nutrigenomics market?
  • How will the urgency of the pandemic influence the global nutrigenomics market?
  • Which are the leading companies dominating the global nutrigenomics market?
  • What is the reimbursement scenario of the tests offered in the global nutrigenomics market?
  • Based on the application type, which global nutrigenomics market application is anticipated to witness a massive rise in demand during the forecast period 2021-2031?
  • How is each segment of the global nutrigenomics market expected to grow during the forecast period, and what revenue is expected to be generated by each of the segments by the end of 2031?
  • How is the global nutrigenomics industry anticipated to evolve during the forecast period 2021-2031?
  • What are the leading trends and consumer preferences witnessed in the global nutrigenomics market?

Market Overview

The concept of nutrigenomics has emerged with an idea to assist an individual in achieving a lasting dietary behavior change that is beneficial for health. Nutrigenomics aims to elucidate the impact of diet on human health. The bioactive food compounds can interact with genes affecting the transcription factors, protein expression, and metabolite production. The study of these complex interactions requires the development of advanced analytical approaches combined with bioinformatics. The advancements in omics technology have opened gateways to deliver the biomarkers for health and comfort, disclose early indicators for a disease disposition, assist in differentiating dietary responders from non-responders, and, last but not least, discover bioactive, beneficial food components.

Further, the increasing rate of obesity and lifestyle-related diseases has led to the rise in the focus on diet-related changes in metabolism and gene. Additionally, the evolution of technology has increased the pace of the market advancements in nutrigenomics.

The segments included in the comprehensive market study are:

  • by Application
  • by Type
    • by Product
    • by Service
  • by Region

The global nutrigenomics market, based on type, is further segmented into product (dietary usage) and by service (nutrigenomic genetic testing). The dietary usage products involve probiotics and prebiotics offered by the company that are impacting the genome directly or indirectly. Further, the genetic testing services in nutrigenomics involved offers insights regarding the diet that has an impact on gene.

Competitive Landscape

The global nutrigenomics market consists of numerous large- and small-scale manufacturers and service providers. Presently, with the increasing rate of molecular advancements and the rise in the adoption of genetic tests, there has been an expansion of opportunities for the nutrigenomics market. Some of the strategies opted by the key players within the market are new product offerings, product approvals, partnerships and alliances, mergers and acquisitions, and business expansions.

In the five years (January 2017- June 2021), the market witnessed 23 product offerings, 25 synergistic activities, six funding and investments, and five business expansions. The increasing awareness for genetic testing and nutrigenomic diet such as prebiotic and probiotic food has majorly attributed to the growing prominence for nutrigenomics.

On the basis of region, North America holds the largest share of the nutrigenomics market owing to improved health consciousness, better genetic testing facilities, and favorable regulatory policies in the region. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.

Table of Contents

1. Nutrigenomics: Product Definition

  • 1.1. Inclusion:
  • 1.2. Exclusion:
    • 1.2.1. Key Questions Answered by the Research Study

2. Research Methodology

  • 2.1. Primary Data Sources
  • 2.2. Secondary Data Sources
  • 2.3. Market Estimation Model
  • 2.4. Assumptions and Limitations

3. Global Nutrigenomics Market: An Overview

  • 3.1. Evolution of Nutrigenomics as Personalized Food
  • 3.2. Nutrigenetics and Nutrigenomics: Focusing on Gene and Diet Interaction
  • 3.3. Scenario of Genetic Testing in Nutrigenomics
  • 3.4. Impact of COVID-19 on Global Nutrigenomics Market
  • 3.5. COVID-19 Affecting Supply Chain of Nutrigenomics Market
  • 3.6. Interruption in Research and Clinical Development and Commercial Operation
    • 3.6.1. Research and Clinical Development
    • 3.6.2. Commercial Operation and Access
  • 3.7. Navigating Crisis Recovery and Looking to the Future

4. Global Nutrigenomics Market: Industry Analysis

  • 4.1. Legal and Regulatory Framework
    • 4.1.1. Legal Requirements and Framework in the U.S.
    • 4.1.2. Legal Requirements and Framework in Europe
    • 4.1.3. Legal Requirements and Framework in Asia-Pacific
      • 4.1.3.1. Japan
      • 4.1.3.2. China
  • 4.2. Patent Landscape

5. Global Nutrigenomics Market: Market Dynamics

  • 5.1. Market Drivers
    • 5.1.1. Rising Advancement in Genomics Technology
    • 5.1.2. Increasing Incidence of Lifestyle-Related Diseases
    • 5.1.3. Increasing Demand for Preventive Medication Through Personalized Nutrition
    • 5.1.4. Limited Efficacy Rate of Drugs
  • 5.2. Market Restraints
    • 5.2.1. Insufficient Application-Based Research Hindering Market Pull
    • 5.2.2. Lack of Awareness Regarding the Usage of Probiotics and Prebiotics
    • 5.2.3. Non-Harmonized Government Regulations on Probiotics and Prebiotics Focusing on Nutrigenomics
  • 5.3. Market Opportunities
    • 5.3.1. Massive Scope for Phenomenal Profits Through Venturous Investments
    • 5.3.2. Integrative Industry-Academia Collaboration
    • 5.3.3. Rise of Next-Generation Probiotics
  • 5.4. Shifting of Reimbursement Policies Toward Enhanced Genetics Coverage

6. Global Nutrigenomics Market: Competitive Landscape

  • 6.1. Key Developments and Strategies
  • 6.2. New Offerings
  • 6.3. Partnerships and Alliances
  • 6.4. Funding & Investment and Business Expansion
  • 6.5. Merger and Acquisition
  • 6.6. Other Strategies
  • 6.7. Market Share Analysis
  • 6.8. Growth-Share Analysis

7. Global Nutrigenomics Market, by Application

  • 7.1. Overview
  • 7.2. Women's Health
  • 7.3. Digestive Health
  • 7.4. Immune Health
  • 7.5. Others

8. Global Nutrigenomics Market, by Type

  • 8.1. Global Nutrigenomics Market, by Product
    • 8.1.1. Probiotics
    • 8.1.2. Prebiotics and Dietary Supplement
  • 8.2. Global Nutrigenomics Market, by Service
    • 8.2.1. Nutrigenomics Genetic Testing (For Clinical Purpose)
    • 8.2.2. Nutrigenomics Genetic Testing (For Research)

9. Global Nutrigenomics Market, by Region

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. Italy
    • 9.3.3. France
    • 9.3.4. U.K.
    • 9.3.5. Spain
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Australia
    • 9.4.5. Rest-of-Asia-Pacific
  • 9.5. Latin America
    • 9.5.1. Brazil
  • 9.6. Mexico
  • 9.7. Rest-of-Latin America
  • 9.8. Rest-of-the-World

10. Company Profiles

  • 10.1. Overview
  • 10.2. BioGaia
    • 10.2.1. Company Overview
    • 10.2.2. Role of Bioagia in the Global Nutrigenomics Market
    • 10.2.3. Financials
    • 10.2.4. SWOT Analysis
  • 10.3. DuPont de Nemours, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Role of DuPont de Nemours, Inc. in the Global Nutrigenomics Market
    • 10.3.3. Financials
    • 10.3.4. SWOT Analysis
  • 10.4. Nutrigenomix Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Role of Nutrigenomix Inc. in the Global Nutrigenomics Market
    • 10.4.3. SWOT Analysis
  • 10.5. MedGenome
    • 10.5.1. Company Overview
    • 10.5.2. Role of MedGenome in the Global Nutrigenomics Market
    • 10.5.3. SWOT Analysis
  • 10.6. Garden of Life, LLC
    • 10.6.1. Company Overview
    • 10.6.2. Role of Garden of Life, LLC in the Global Nutrigenomics Market
    • 10.6.3. SWOT Analysis
  • 10.7. Ingredion Incorporated
    • 10.7.1. Company Overview
    • 10.7.2. Role of Ingredion Incorporated in the Global Nutrigenomics Market
    • 10.7.3. Financials
    • 10.7.4. SWOT Analysis
  • 10.8. Jarrow Formulas Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Role of Jarrow Formulas Inc. in the Global Nutrigenomics Market
    • 10.8.3. SWOT Analysis
  • 10.9. geneOmbio
    • 10.9.1. Company Overview
    • 10.9.2. Role of geneOmbio in the Global Nutrigenomics Market
    • 10.9.3. SWOT Analysis
  • 10.1. GX Sciences, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Role of GX Sciences, Inc.in the Global Nutrigenomics Market
    • 10.10.3. SWOT Analysis
  • 10.11. DNAfit
    • 10.11.1. Company Overview
    • 10.11.2. Role of DNAfit in the Global Nutrigenomics Market
    • 10.11.3. SWOT Analysis
  • 10.12. Yakult Honsha Co., Ltd.
    • 10.12.1. Company Overview
    • 10.12.2. Role of Yakult Honsha Co., Ltd. in the Global Nutrigenomics Market
    • 10.12.3. Financials
    • 10.12.4. SWOT Analysis
  • 10.13. Koninklijke DSM N.V.
    • 10.13.1. Company Overview
    • 10.13.2. Role of Koninklijke DSM N.V. in the Global Nutrigenomics Market
    • 10.13.3. Financials
    • 10.13.4. SWOT Analysis
  • 10.14. XCODE Life
    • 10.14.1. Company Overview
    • 10.14.2. Role of XCODE Life in the Global Nutrigenomics Market
    • 10.14.3. SWOT Analysis

List of Tables

  • Table 3.1: Impact of SNP and Nutrition Health
  • Table 7.1: Documented Microbial Associations with Disease Status

List of Figures

  • Figure 1: Prevalence of Obesity in the U.S.
  • Figure 2: Global Nutrigenomics Market, 2020-2031
  • Figure 3: Impact Analysis
  • Figure 4: Global Nutrigenomics Market Growth-Share Analysis (by Company), 2020
  • Figure 1.1: Concept of Extended Nutrigenomics
  • Figure 1.2: Global Nutrigenomics Market Segmentation
  • Figure 2.1: Global Nutrigenomics Market Research Methodology
  • Figure 2.2: Primary Research Methodology
  • Figure 2.3: Bottom-up Approach
  • Figure 3.1: Global Nutrigenomics Market, 2020-2031
  • Figure 3.2: Global Nutrigenomics Market, by Product (Dietary Usage), 2020-2031
  • Figure 3.3: Global Nutrigenomics Market, by Service (Nutrigenomic Genetic Testing), 2020-2031
  • Figure 3.4: Anatomy of Gene Diet Interaction
  • Figure 3.5: Positive and Negative Impact of COVID-19 on Global Nutrigenomics Market
  • Figure 3.6: Pre-COVID-19 and Post-COVID-19 Scenario of Global Nutrigenomics Market
  • Figure 3.7: Measure to Navigate Crisis Recovery
  • Figure 4.1: Guidelines for the Evaluation of Probiotics for Food Use
  • Figure 4.2: Number of Patents (by Year), 2017-2020
  • Figure 5.1: Impact Analysis
  • Figure 5.2: Diet and Disease Linkage
  • Figure 5.3: Deaths Owing to Non-Communicable Disorders, 2015-2019
  • Figure 6.1: Share of Key Developments and Strategies, January 2018-June 2021
  • Figure 6.2: Product Offering Share (by Company), January 2018-June 2021
  • Figure 6.3: Partnerships and Alliances Activities Share (by Company), January 2018- June 2021
  • Figure 6.4: Funding & Investment and Business Expansion (by Company), January 2018-June 2021
  • Figure 6.5: Mergers and Acquisitions (by Company), January 2018-June 2021
  • Figure 6.6: Other Activities (by Company), January 2018-June 2021
  • Figure 6.7: Global Nutrigenomics Market Share Analysis, by Dietary Usage 2020
  • Figure 6.8: Global Nutrigenomics Market Share Analysis , by Nutrigenomic Testing Market, 2020
  • Figure 6.9: Global Nutrigenomics Market Growth-Share Analysis (by Company), 2020
  • Figure 7.1: Share of Global Nutrigenomics Market (by Application), $Million, 2020-2031
  • Figure 7.2: Inter-Related Factors Governing Women's Health
  • Figure 7.3: Global Nutrigenomics Market, by Women's Health, 2020-2031
  • Figure 7.4: Global Nutrigenomics Market, by Digestive Health, 2020-2031
  • Figure 7.5: Global Nutrigenomics Market, by Immune Health, 2020-2031
  • Figure 7.6: Global Nutrigenomics Market, by Other Applications, 2020-2031
  • Figure 8.1: Global Nutrigenomics Market, by Product, 2020-2031
  • Figure 8.2: Global Nutrigenomics Market, by Probiotics, 2020-2031
  • Figure 8.3: Global Nutrigenomics Market, by Prebiotics and Dietary Supplement, 2020-2031
  • Figure 8.4: Effect of genes on different aspects of health
  • Figure 8.5: Global Nutrigenomics Market, by Nutrigenomic Genetic Testing (For Clinical Purpose), 2020-2031
  • Figure 8.6: Global Nutrigenomics Market, by Nutrigenomic Genetic Testing (For Research Purpose), 2020-2031
  • Figure 9.1: North America Nutrigenomics Market, 2020-2031
  • Figure 9.2: North America: Market Dynamics
  • Figure 9.3: North America Nutrigenomics Market (by Country), 2020-2031
  • Figure 9.4: U.S. Nutrigenomics Market, 2020-2031
  • Figure 9.5: Canada Nutrigenomics Market, 2020-2031
  • Figure 9.6: Europe Nutrigenomics Market, 2020-2031
  • Figure 9.7: Europe: Market Dynamics
  • Figure 9.8: Europe Nutrigenomics Market (by Country), 2020-2031
  • Figure 9.9: Germany Nutrigenomics Market, 2021-2031
  • Figure 9.10: Italy Nutrigenomics Market, 2020-2031
  • Figure 9.11: France Nutrigenomics Market, 2020-2031
  • Figure 9.12: U.K. Nutrigenomics Market, 2020-2031
  • Figure 9.13: Spain Nutrigenomics Market, 2020-2031
  • Figure 9.14: Asia-Pacific Nutrigenomics Market, 2020-2031
  • Figure 9.15: Asia-Pacific: Market Dynamics
  • Figure 9.16: Asia-Pacific Nutrigenomics Market (by Country), 2020-2031
  • Figure 9.17: China Nutrigenomics Market, 2021-2031
  • Figure 9.18: Japan Nutrigenomics Market, 2020-2031
  • Figure 9.19: India Nutrigenomics Market, 2021-2031
  • Figure 9.20: Australia Nutrigenomics Market, 2020-2031
  • Figure 9.21: Rest-of-Asia-Pacific Nutrigenomics Market, 2020-2031
  • Figure 9.22: Latin America Nutrigenomics Market, 2020-2031
  • Figure 9.23: Latin America: Market Dynamics
  • Figure 9.24: Latin America Nutrigenomics Market (by Country), 2020 and 2031
  • Figure 9.25: Brazil Nutrigenomics Market, 2020-2031
  • Figure 9.26: Mexico Nutrigenomics Market, 2020-2031
  • Figure 9.27: Rest-of-Latin America Nutrigenomics Market, 2020-2031
  • Figure 9.28: Rest-of-the-World Nutrigenomics Market, 2020-2031
  • Figure 10.1: Shares of Key Company Profiles
  • Figure 10.2: BioGaia: Overall Product Offerings
  • Figure 10.3: BioGaia: Overall Financials, 2018-2020
  • Figure 10.4: BioGaia: Revenue (by Region), 2018-2020
  • Figure 10.5: BioGaia: R&D Expenditure, 2018-2020
  • Figure 10.6: BioGaia: SWOT Analysis
  • Figure 10.7: DuPont de Nemours, Inc.: Overall Product Offerings
  • Figure 10.8: DuPont de Nemours, Inc.: Overall Financials, 2018-2020
  • Figure 10.9: DuPont de Nemours, Inc.: Revenue (by Region), 2018-2020
  • Figure 10.10: DuPont de Nemours, Inc.: R&D Expenditure, 2018-2020
  • Figure 10.11: DuPont de Nemours, Inc.: SWOT Analysis
  • Figure 10.12: Nutrigenomix Inc.: Overall Product Offerings
  • Figure 10.13: Nutrigenomix Inc.: SWOT Analysis
  • Figure 10.14: MedGenome: Overall Product Portfolio
  • Figure 10.15: MedGenome: SWOT Analysis
  • Figure 10.16: Garden of Life, LLC: Overall Product Portfolio
  • Figure 10.17: Garden of Life, LLC: SWOT Analysis
  • Figure 10.18: Ingredion Incorporated: Overall Product Offerings
  • Figure 10.19: Ingredion Incorporated: Overall Financials, 2018-2020
  • Figure 10.20: Ingredion Incorporated: Revenue (by Segment), 2018-2020
  • Figure 10.21: Ingredion Incorporated: Revenue (by Region), 2018-2020
  • Figure 10.22: Ingredion Incorporated: R&D Expenditure, 2018-2020
  • Figure 10.23: Ingredion Incorporated: SWOT Analysis
  • Figure 10.24: Jarrow Formulas Inc.: Overall Product Portfolio
  • Figure 10.25: Jarrow Formulas Inc.: SWOT Analysis
  • Figure 10.26: geneOmbio: Product Portfolio for Nutrigenomics Market
  • Figure 10.27: geneOmbio.: SWOT Analysis
  • Figure 10.28: GX Sciences, Inc.: Overall Product Offerings
  • Figure 10.29: GX Sciences, Inc.: SWOT Analysis
  • Figure 10.30: DNAfit: Overall Product Offerings
  • Figure 10.31: DNAfit: SWOT Analysis
  • Figure 10.32: Yakult Honsha Co., Ltd.: Overall Product Offerings
  • Figure 10.33: Yakult Honsha Co., Ltd: Overall Financials, 2017-2019
  • Figure 10.34: Yakult Honsha Co., Ltd: Revenue (by Segment), 2017-2019
  • Figure 10.35: Yakult Honsha Co., Ltd.: SWOT Analysis
  • Figure 10.36: Koninklijke DSM N.V.: Overall Product Offerings
  • Figure 10.37: Koninklijke DSM N.V.: Overall Financials, 2018-2020
  • Figure 10.38: Koninklijke DSM N.V.: Revenue (by Segment), 2018-2020
  • Figure 10.39: Koninklijke DSM N.V.: Revenue (by Region), 2018-2020
  • Figure 10.40: Koninklijke DSM N.V.: R&D Expenditure, 2018-2020
  • Figure 10.41: Koninklijke DSM N.V.: SWOT Analysis
  • Figure 10.42: XCODE Life: Overall Product Portfolio
  • Figure 10.43: XCODE Life: SWOT Analysis